May 16th 2024
Paula Emanuela Voinescu, MD, PhD, director of the Women's Epilepsy Program at Brigham and Women's Hospital, talked about the influence of sex hormones on maternal outcomes in pregnant women with epilepsy treated with antiseizure medication.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
US bill for false-positive mammograms: $4 billion annually
April 8th 2015A recent report sheds light on how much false-positives and overdiagnosis of breast cancer cost. Additionally, new research examines the impact of the number of live births on future heart health in the mother and provides further evidence of the efficacy of cfDNA testing.
Read More
UK approves three-parent fertility treatments and more research
February 11th 2015A form of assisted reproductive technology that could make it possible for women with mutations in mitochondrial DNA to give birth to children free of mitochondrial disease has been approved by UK’s House of Commons. A Food and Drug Administration (FDA) committee is considering granting similar approval for use of the technique-known as oocyte modification or three-parent gene therapy-in the United States.
Read More
SMFM Clinical Guideline: Nonimmune Hydrops Fetalis
February 6th 2015A summary of the evidence-based SMFM guidelines for the evaluation and management of nonimmune hydrops fetalis (NIHF). The guidelines cover the epidemiology, risk factors, work-up, prognosis, and treatment of pregnancies complicated by NIHF.
Read More
Tighter prenatal hypertension control doesn’t result in larger babies, later births
February 4th 2015Tight control of hypertension in pregnancy does not produce better perinatal outcomes or fewer serious maternal complications than looser control, according to results of an international randomized clinical trial. Published in the New England Journal of Medicine, the findings are consistent with those from a meta-analysis of 29 previous trials.
Read More
FDA updates labeling of drugs for pregnant and lactating women
December 10th 2014The US Food and Drug Administration (FDA) recently issued a final rule altering how the labels for physicians on prescription drugs and biological products provide information for pregnant and breastfeeding women.
Read More
AAGL Stump the Professors Score: Experts 1, Presenters 2
November 21st 2014A panel of experts were bested only once at the “Stump the Professors” session at the 43rd AAGL Global Congress on Minimally Invasive Gynecology in Vancouver. A sarcoma was the diagnosis that got away among three complex cases presented to a packed audience.
Read More
Does cryopreservation of embryos increase risk of placenta accreta?
November 19th 2014A small study by investigators from Harvard University suggests that cryopreserved embryo transfer (CET) is a strong independent risk factor for placenta accreta in women undergoing in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI).
Read More
March of Dimes report: US preterm birth rate at 17-year low
November 14th 2014The 7th annual March of Dimes Premature Birth Report Card shows that in 2013, the preterm birth rate fell to its lowest in 17 years-11.5%--meeting Healthy People 2020 goals. That number, however, still earns a “C” grade from the organization, which has set a goal of 9.6% of all live births by 2020.
Read More